Literature DB >> 14769539

Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis.

Luciana Passos Toledo1, Thomas Prates Ong, Ana Lúcia Galvão Pinho, Alceu Jordão, Hélio Vanucchi, Fernando Salvador Moreno.   

Abstract

Inhibitory effects of lutein (LUT) and lycopene (LYC) on hepatic preneoplastic lesions (PNLs) and DNA strand breakage induced in Wistar rats by the resistant hepatocyte (RH) model of hepatocarcinogenesis were investigated. Animals received by gavage during 8 consecutive weeks on alternate days 70 mg/kg body weight of LUT or LYC. Rats treated with only corn oil and submitted to this model were used as controls. At the end of the experiment, treatment of the animals with LUT or LYC resulted in an increase in the respective liver carotenoid concentrations (P < 0.05). Moreover, it tended to reduce the incidence, total number, and multiplicity of hepatocyte nodules compared with the control group, although the differences did not reach statistical significance. Animals treated with LUT or LYC presented also a lower number of hepatic placental glutathione S-transferase-positive (GST-P) PNLs (P < 0.05), which were smaller (P < 0.05) and occupied a smaller area of the liver section (P < 0.05). Finally, hepatic DNA strand breakage evaluated by the comet assay was lower (P < 0.05) in carotenoid-treated animals when compared with the control group. Therefore, the results indicate that LUT and LYC represent promising chemopreventive agents during hepatocarcinogenesis and whose anticarcinogenic actions could be related to a protection against DNA instability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769539     DOI: 10.1207/s15327914nc4701_8

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  8 in total

1.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

2.  Terpenoids as potential chemopreventive and therapeutic agents in liver cancer.

Authors:  Roslin J Thoppil; Anupam Bishayee
Journal:  World J Hepatol       Date:  2011-09-27

3.  Lycopene attenuated hepatic tumorigenesis via differential mechanisms depending on carotenoid cleavage enzyme in mice.

Authors:  Blanche C Ip; Chun Liu; Lynne M Ausman; Johannes von Lintig; Xiang-Dong Wang
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-07

4.  Apo-10'-lycopenoic acid, a lycopene metabolite, increases sirtuin 1 mRNA and protein levels and decreases hepatic fat accumulation in ob/ob mice.

Authors:  Jayong Chung; Kyeongok Koo; Fuzhi Lian; Kang Quan Hu; Hansgeorg Ernst; Xiang-Dong Wang
Journal:  J Nutr       Date:  2012-01-18       Impact factor: 4.798

5.  Anti-Cancer Effects of Lycopene in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Abraham Nigussie Mekuria; Abera Kenay Tura; Bisrat Hagos; Mekonnen Sisay; Jemal Abdela; Kirubel Minsamo Mishore; Birhanu Motbaynor
Journal:  Front Pharmacol       Date:  2020-08-21       Impact factor: 5.810

6.  Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats.

Authors:  Yan Wang; Lynne M Ausman; Andrew S Greenberg; Robert M Russell; Xiang-Dong Wang
Journal:  Int J Cancer       Date:  2010-04-15       Impact factor: 7.396

Review 7.  New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene.

Authors:  Boon-Peng Puah; Juriyati Jalil; Ali Attiq; Yusof Kamisah
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

Review 8.  Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.

Authors:  Blanche C Ip; Xiang-Dong Wang
Journal:  Nutrients       Date:  2013-12-27       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.